Cargando…

X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery

Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compou...

Descripción completa

Detalles Bibliográficos
Autores principales: Amporndanai, Kangsa, Johnson, Rachel M., O’Neill, Paul M., Fishwick, Colin W. G., Jamson, Alexander H., Rawson, Shaun, Muench, Stephen P., Hasnain, S. Samar, Antonyuk, Svetlana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947725/
https://www.ncbi.nlm.nih.gov/pubmed/29765610
http://dx.doi.org/10.1107/S2052252518001616
_version_ 1783322427777875968
author Amporndanai, Kangsa
Johnson, Rachel M.
O’Neill, Paul M.
Fishwick, Colin W. G.
Jamson, Alexander H.
Rawson, Shaun
Muench, Stephen P.
Hasnain, S. Samar
Antonyuk, Svetlana V.
author_facet Amporndanai, Kangsa
Johnson, Rachel M.
O’Neill, Paul M.
Fishwick, Colin W. G.
Jamson, Alexander H.
Rawson, Shaun
Muench, Stephen P.
Hasnain, S. Samar
Antonyuk, Svetlana V.
author_sort Amporndanai, Kangsa
collection PubMed
description Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc (1) that may be available from parasites, all efforts have been focused on homologous cytochrome bc (1) complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc (1) is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to ∼4.1 Å resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes.
format Online
Article
Text
id pubmed-5947725
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-59477252018-05-15 X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery Amporndanai, Kangsa Johnson, Rachel M. O’Neill, Paul M. Fishwick, Colin W. G. Jamson, Alexander H. Rawson, Shaun Muench, Stephen P. Hasnain, S. Samar Antonyuk, Svetlana V. IUCrJ Research Papers Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc (1) that may be available from parasites, all efforts have been focused on homologous cytochrome bc (1) complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc (1) is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to ∼4.1 Å resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes. International Union of Crystallography 2018-02-20 /pmc/articles/PMC5947725/ /pubmed/29765610 http://dx.doi.org/10.1107/S2052252518001616 Text en © Kangsa Amporndanai et al. 2018 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/2.0/uk/
spellingShingle Research Papers
Amporndanai, Kangsa
Johnson, Rachel M.
O’Neill, Paul M.
Fishwick, Colin W. G.
Jamson, Alexander H.
Rawson, Shaun
Muench, Stephen P.
Hasnain, S. Samar
Antonyuk, Svetlana V.
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title_full X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title_fullStr X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title_full_unstemmed X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title_short X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
title_sort x-ray and cryo-em structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947725/
https://www.ncbi.nlm.nih.gov/pubmed/29765610
http://dx.doi.org/10.1107/S2052252518001616
work_keys_str_mv AT amporndanaikangsa xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT johnsonrachelm xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT oneillpaulm xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT fishwickcolinwg xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT jamsonalexanderh xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT rawsonshaun xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT muenchstephenp xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT hasnainssamar xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery
AT antonyuksvetlanav xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery